REBINYN

Описание товара

About REBINYN

REBINYN is a recombinant coagulation factor IX product, specifically designed to treat and prevent bleeding episodes in patients with hemophilia B. This medication is formulated with a pegylated version of coagulation factor IX, which helps to prolong its activity and reduce the frequency of injections.

Key Benefits & Uses

• Treatment and prevention of bleeding episodes in patients with hemophilia B
• On-demand treatment of bleeding episodes
• Prophylactic treatment to prevent bleeding episodes

Active Ingredient & Action

REBINYN contains coagulation factor IX (recombinant), pegylated, which is a protein that helps to stop bleeding by promoting the formation of blood clots. When administered, this protein binds to specific receptors on platelets and helps to activate the coagulation cascade, leading to the formation of a stable blood clot.

Important Notes

REBINYN should only be used under the guidance of a healthcare professional. Patients should be carefully monitored for signs of hypersensitivity reactions, such as anaphylaxis, and should be instructed on proper injection techniques. Additionally, patients should be advised to report any signs of bleeding or bruising to their healthcare provider promptly.